Lipodystrophy clinical trials

Explore recruiting lipodystrophy clinical trials.

Recruiting lipodystrophy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Lipodystrophy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A 24-Month, Multi-Centre, Open Label Phase IV Post Authorisation Efficacy Study to Evaluate the Efficacy, Safety and Immunogenicity of Daily Subcutaneous Metreleptin Treatment in Patients with Partial Lipodystrophy

Italy, Germany, France

Therapeutic use (Phase IV) EU CTIS Study details

Open-label, Phase 3b study to evaluate effectiveness, safety and pharmacokinetic parameters of metreleptin in patients under 6 years of age with generalised lipodystrophy and associated diabetes mellitus and/or hypertriglyceridaemia

Italy, Germany, Belgium, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A 12-Month Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study to Evaluate the Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Subjects with Partial Lipodystrophy

Spain, Netherlands, Belgium, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Lipodystrophy trials by city

Lipodystrophy in Toronto Lipodystrophy in Vancouver Lipodystrophy in Montreal Lipodystrophy in Calgary Lipodystrophy in Edmonton Lipodystrophy in Ottawa Lipodystrophy in Winnipeg Lipodystrophy in Quebec City Lipodystrophy in Hamilton Lipodystrophy in Kitchener Lipodystrophy in London Lipodystrophy in Halifax Lipodystrophy in New York Lipodystrophy in Los Angeles Lipodystrophy in Chicago Lipodystrophy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease